Compounds > adenine

adenine and pentoxifylline

adenine has been researched along with pentoxifylline in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Al-Humidan, A; Al-Sedairy, ST; Al-Sofi, A; Dzimiri, M; Edwards, CK; Khabar, KS1
Bourguignon, JJ; Lugnier, C; Muller, CD; Pinna, G; Raboisson, P; Reimund, JM1
Bourguignon, JJ; Gazi, L; Keravis, T; Lugnier, C; Monneaux, F; Muller, S; Yougbaré, I1

Other Studies

5 other study(ies) available for adenine and pentoxifylline

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
A carbocyclic nucleoside analogue is a TNF-alpha inhibitor with immunosuppressive action: role of prostaglandin E2 and protein kinase C and comparison with pentoxifylline.
    Cellular immunology, 1998, Aug-25, Volume: 188, Issue:1

    Topics: Adenine; Dinoprostone; Humans; Immunosuppressive Agents; Interleukin-8; Isoantigens; Leukocytes, Mononuclear; Lymphocyte Culture Test, Mixed; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Superantigens; T-Lymphocytes; Tumor Necrosis Factor-alpha

1998
Anti-TNF-alpha properties of new 9-benzyladenine derivatives with selective phosphodiesterase-4- inhibiting properties.
    Biochemical and biophysical research communications, 2001, Oct-26, Volume: 288, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Benzamides; Cell Survival; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Drug Interactions; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Tumor Necrosis Factor-alpha; Xanthines

2001
Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.
    PloS one, 2012, Volume: 7, Issue:1

    Topics: Adenine; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Progression; Female; Humans; Isoenzymes; Kidney; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mice; Mice, Inbred CBA; Mice, Inbred MRL lpr; Pentoxifylline; Phosphodiesterase 4 Inhibitors; Proteinuria; Survival Rate; Tumor Necrosis Factor-alpha; Xanthines

2012